JCNRJournal of Clinical and Nursing Research2208-36852208-3693Bio-Byword Scientific Publishing Pty. Ltd.10.26689/jcnr.v8i9.8394ArticleEffectiveness of Chuzhi Shengfa Tablets Combined with Ketoconazole Shampoo and Chuzhi Shengfa Tablets Combined with 5% Minoxidil Foam in the Treatment of Male Androgenetic Alopeciahttps://artdesignp.com/journal/JCNR/8/9/10.26689/jcnr.v8i9.8394WeiJianming,LiYu,ZhangLi,WangRui,ChenLu,ZhaoJiaojiao,LiJia2024892024-09-27Objective: To investigate the clinical efficacy and safety of Chuzhi Shengfa Tablets combined with ketoconazole shampoo and Chuzhi Shengfa Tablets combined with 5% minoxidil foam in the treatment of male androgenetic alopecia. Methods: From July 2022 to July 2023, 120 male patients with androgenetic alopecia were selected from our Department of Dermatology and randomly divided into Control Group 1, Control Group 2, Observation Group 1, and Observation Group 2, with 30 patients in each group. Control Group 1 was treated with ketoconazole shampoo, Control Group 2 with 5% minoxidil foam, Observation Group 1 with ketoconazole shampoo combined with Chuzhi Shengfa Tablets, and Observation Group 2 with 5% minoxidil foam combined with Chuzhi Shengfa Tablets. Hair density, hair diameter, scalp oil secretion (using oil secretion scoring), and adverse reactions were compared before and after treatment across the four groups. Results: After treatment, hair density and hair diameter significantly increased in all four groups compared to before treatment, while scalp oil secretion scores significantly decreased (P < 0.05). The improvements in Observation Groups 1 and 2 were significantly better than those in Control Groups 1 and 2 (P < 0.05). No significant differences in the incidence of adverse reactions were observed among the four groups (P > 0.05). Conclusion: Chuzhi Shengfa Tablets combined with ketoconazole shampoo and Chuzhi Shengfa Tablets combined with 5% minoxidil foam are both effective and safe for treating male androgenetic alopecia. These combinations can significantly improve hair growth and are worthy of clinical promotion.

Xu F, Yang QP, Zhou J, et al., 2006, Quality of Life Survey and Analysis of 526 Cases of Androgenetic Alopecia. Journal of Capital Medical University, 2006(6): 740–742.

Hu ZQ, Miao Y, 2019, Guidelines for the Diagnosis and Treatment of Androgenetic Alopecia in Chinese People. Chinese Journal of Aesthetic and Plastic Surgery, 30(1): 8–12.

Xu JJ, Zheng YY, Hu LF, et al., 2013, Factors Affecting Poor Treatment Compliance in Patients with Androgenetic Alopecia. Journal of Clinical Dermatology, 42(7): 405–409.

Dong JH, Zhang GP, Huang XX, 2014, Combination of Chuzhi Shengfa Tablets and Glycyrrhizin Zinc Granules in the Treatment of Early Androgenetic Alopecia in Males. Chinese Journal of Aesthetic Medicine, 23(10): 846–848.

Cheong WK, Yeung CK, Torsekar RG, et al., 2016, Treatment of Seborrhoeic Dermatitis in Asia: A Consensus Guide. Skin Appendage Disord, 1(4): 187–196. https://doi.org/10.1159/000444682

Yang XS, Ding YX, Chen YH, et al., 2024, Preliminary Study on the Early Hair Loss Phenomenon Treated with 5% Minoxidil Combined with Oral Antiandrogens for Androgenetic Alopecia. Journal of Clinical Dermatology, 53(4): 199–203.

Zhao M, Wu QF, Zhou LB, et al., 2024, Clinical Efficacy and Safety Observation of 5% Minoxidil Foam in the Treatment of Male Androgenetic Alopecia. Journal of Clinical Dermatology, 53(9): 519–522.

Zhuang XS, Xu JJ, Zheng YY, et al., 2012, Classification and Grading Methods of Androgenetic Alopecia. Journal of Clinical Dermatology, 41(12): 768–771.

Zhou JF, 2017, Chuzhi Shengfa Tablets Combined with Compound Fluocinolone Acetonide Tincture in the Treatment of Male Androgenetic Alopecia. Chinese Journal of Aesthetic Medicine, 26(7): 73–74 + 141.

Li Y, 2022, Study on the Effect of 60Co-Gamma Ray Sterilization on the Chemical Components of Chuzhi Shengfa Tablets Based on HPLC Fingerprint. Chinese Pharmacist, 25(7): 1271.

Yang H, 2016, Clinical Observation of Chuzhi Shengfa Tablets Combined with Compound Fluocinolone Acetonide Tincture in the Treatment of Male Androgenetic Alopecia. Dermatology and Venereology, 38(3): 219–220.

Sun RL, Wang HY, Wang ZX, 2020, Efficacy Observation of 1% Butenafine Hydrochloride Cream Combined with 2% Ketoconazole Shampoo in the Treatment of Pityriasis Versicolor. Chinese Rational Drug Use Exploration, 17(7): 74–76.